Reuters logo
5 months ago
BRIEF-Infinity expects net loss for 2017 to range from $40 mln-$50 mln
March 14, 2017 / 8:24 PM / 5 months ago

BRIEF-Infinity expects net loss for 2017 to range from $40 mln-$50 mln

March 14 (Reuters) - Infinity Pharmaceuticals Inc:

* Infinity provides company update and reports fourth quarter 2016 financial results

* Infinity Pharmaceuticals Inc- expects net loss for 2017 to range from $40 million to $50 million

* Infinity Pharmaceuticals- expects to end 2017 with year-end cash, cash equivalents, available-for-sale securities balance ranging from $40 million-$50 million

* Infinity Pharma- expects existing cash, cash equivalents, available-for-sale securities at Dec. 31, 2016, adequate to satisfy capital needs into Q1 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below